Phase-3 study to evaluate efficacy and safety of ertugliflozin monotherapy.
Read More »Production Assistant, Diabetes In Control
Lowering the Risk of Diabetes By Just Sitting Less
A new study suggests that people who spend time walking or even just standing instead of sitting may be at lower risk of type 2 diabetes.
Read More »Question #871
Hypoglycemia is a potential side effect of which of the following classes of drugs: 1) Insulins 2) Sulfonylureas 3) Meglitinides 4) Amylin mimetics 5) All of the above Follow the link to see the right answer!
Read More »Life Happens to Our Patients Too. Be Understanding.
Woman, type 1 diabetes, 63 years of age. Well-educated diabetes wise. Reached out to me saying: "HELP!! Normally I take 10 units of Toujeo at 9 pm. I did that last night. This morning I meant to take an additional 2 units because I'm not getting any exercise due to a knee injury. By mistake I took my usual dose of 10 units." Before I read the rest of her email, I thought, I know her. She knows what to do. She wears a CGM, she’ll be watching that. Then I read on...
Read More »EMPA-REG Outcome Trial, Part 7
In this week's Homerun Slides, the ratios of the adverse events in patients and their tolerability of the placebo vs empagliflozin.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #60: Mechanisms of Insulin Signal Transduction Part 4 of 8
PI-3 kinase pathways: regulation of metabolism and gene expression: Signal transduction for insulin’s metabolic effects also diverges from insulin receptor substrate proteins and proceeds via the PI-3 kinase pathway. The first committed step involves type 1A PI-3 kinase, a heterodimer consisting of a p85 regulatory subunit and a p110 catalytic subunit. In quiescent cells, the regulatory subunit maintains a state of low activity for the catalytic subunit.
Read More »Remission of Prediabetes to Normal Glucose Tolerance in Obese Adults
The use of a high protein diet instead of a high carbohydrate diet to help reverse the progression to diabetes.
Read More »Continuous Glucose Monitoring To Improve Diabetes Control
Two studies show use of sensor implanted under skin that continuously monitors glucose levels resulted in improved levels in T1 patients who inject insulin multiple times a day.
Read More »A New Combination Diabetes Treatment Could Become the Standard Instead of Insulin
Study shows significant improvement in diabetes control with a 1 point drop in A1c with less hypoglycemia.
Read More »Metformin Not the Only Treatment for Prediabetes
Pioglitazone in people with insulin resistance, prediabetes or diabetes is associated with a decreased risk for major adverse cardiovascular events, study data shows.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.